BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 7, 2018
View Archived Issues
PI3Kdelta in autoimmunity
Read More
Ketamine activates opioid system
Read More
Repeat expansions disrupt large-scale genome organization
Read More
HECTD3 negatively regulates host defense against intracellular bacteria by modulation of type I IFN
Read More
Complete response observed in phase I study of ET-140202 in metastatic HCC
Read More
Brain immune cells show multiple sex differences
Read More
TSI initiates phase II study of its novel treatment regimen for ischemic stroke
Read More
Yumanity Therapeutics names first clinical candidate for Parkinson's disease
Read More
MabSpace initiates Chinese phase I trial of MSB-2311, files IND for MSB-0254
Read More
C11orf95-RELA fusion drives ST-ependymoma formation through NF-kappaB and other signaling pathways
Read More
Beta1-integrin promotes endothelial barrier disruption: a new target to prevent vascular leakage
Read More
HAS2 gene linked to the pathogenesis of lower extremity varicose veins
Read More
Combining ACE2 and BNP biomarkers improves risk stratification in patients with aortic stenosis
Read More
Researchers identify FHOD3 as a novel disease-causing gene in hypertrophic cardiomyopathy
Read More
Torrent Pharmaceuticals patents compounds for asthma and COPD
Read More
A*STAR identifies new SMYD3 inhibitors for cancer
Read More
Xenon Pharmaceuticals to develop ezogabine for KCNQ2 epileptic encephalopathy
Read More
Chinese researchers disclose Abeta aggregation inhibitors
Read More
FDA approves Tiglutik oral suspension for the treatment of ALS
Read More
Phase IIa study of Yeliva for cholangiocarcinoma advances to second stage
Read More
Eli Lilly presents AOC3 inhibitors
Read More
Luye initiates phase III trials in China with LY-01005 for prostate cancer
Read More
Atara Biotherapeutics to develop CAR T immunotherapies with Moffitt Cancer Center
Read More
NIH grants supports Hepseros' development of human-on-a-chip technology
Read More
Soleno amends phase III trial protocol for diazoxide choline in Prader-Willi syndrome
Read More
Checkpoint Therapeutics reports promising phase I/II data with CK-101 in EGFR-mutated NSCLC
Read More
Compugen initiates clinical testing of COM-701 in advanced solid tumors
Read More
